end-stage chronic liver disease, as well as rare situations of unexpected failure of a previously healthy liver, would benefit through this MOU. The MoU was signed by Dr. Sandeep Shrivastava, CEO, Group of Hospitals – DMIMS, Delhi University, and Dr. Anupam Sibal, Group Medical Director, Apollo Hospitals Group.
Sangita Reddy, Joint Managing Director, Apollo Hospitals, expressed optimism over the partnership and highlighted the benefits of this program. She said, “This MOU is the first of its kind in Central India and will change the scenario of liver transplant in the region. Apollo Hospitals’ liver transplant program is a beacon of quality and hope for patients from across the world. This will be a boon to patients in need of liver transplant in terms of cost and convenience and they will not have to travel to other cities and states for treatment.”
Dr. Manish Varma, senior liver transplant surgeon at Apollo Hospitals spoke about the challenges in the liver transplant operational process and highlighted the benefits of the newly signed MoU. He said, “The number of patients with liver disease has shown a sharp increase over the last decade. An estimated 2 lac patients die of liver failure or liver cancer annually in India, about 10-15% of which can be saved with a timely liver transplant. Today, over 30000 liver transplants are needed every year to save the lives of patients with end-stage liver disease, but only about 1500 are being performed. With the MOU between the two institutions, liver transplants in Central India are expected to receive a boost, hence saving lives and eliminating the need to travel to other cities and states for treatment”.
